CCI approves acquisition of certain shareholding in Balaji Wafers by General Atlantic Singapore (See 'Corp Brief') CCI approves combination of Bagmane Prime Office REIT of Bagmane Developers and others (See 'Corp Brief') CCI okays acquisition of additional equity in Generali Central Insurance by Central Bank (See 'Corp Brief') India and Finland renew MoU on Environmental Cooperation (See 'Corp Brief') IPR - Proof of right refers to documents showing that applicant legally owns 'right to apply for patent', which can be established through assignment or employment agreement with inventor: HC (See 'Legal Desk') Crude and Petroleum procurement: 24×7 Control Room Monitoring Supply Position (See 'Corp Brief') On World Wildlife Day 2026, PM reaffirms Commitment to Wildlife Conservation (See 'Corp Brief') IBC - valuers must ensure a reasoned valuation report to guide stakeholders in economic decision-making during insolvency, including consideration of intangible assets where relevant: IBBI (See 'Legal Desk') GPS transforming fishing community lives in Car Nicobar (See 'Corp Brief') Competition Act - disputes concerning alteration of copyrighted content & associated rights, need not be entertained where no prima facie case of anti-competitive agreement or abuse of dominant position, is made out: CCI (See 'Legal Desk') Ministry of Steel holds Interactive Session with Global Diplomats Ahead of 'Bharat Steel 2026' (See 'Corp Brief') Khadse announces unique nationwide ASMITA League to mark International Women's Day (See 'Corp Brief') IPR – Anti-dissection rule, which requires trademarks to be compared as whole, does not apply where part of mark is proven to be dominant feature: HC (See 'Legal Desk') India Summit 2026: Major AI Investment Commitments made (See 'Corp Brief') Joshi commends CWC's Contribution to India's Food Security (See 'Corp Brief') SEBI - Termination of a major acquisition agreement constituted a material event requiring clear & conspicuous disclosure under Regulation 30 of the LODR Regulations: SAT (See 'Legal Desk') India invites the world to study, innovate and grow together (See 'Corp Brief') SEBI - Investor decisions & share prices are significantly influenced by disclosures relating to acquisitions & corporate developments, ergo, failure to transparently disclose termination undermines market integrity: SAT (See 'Legal Desk') Controller General of Communication Accounts inaugurates North Zone Review Meeting (See 'Corp Brief') National Arogya Fair 2026 concludes in Shegaon (See 'Corp Brief') IPR - For purpose of passing-off claim, prior use of composite trademark is sufficient to establish prior use of its essential and source-identifying component: HC (See 'Legal Desk') APEDA organises Sikkim Organic Conclave-cum-International Buyer Seller Meet in Gangtok (See 'Corp Brief') 'Double Engine' Momentum Can Fast-Track Kerala's Progress: MoS (See 'Corp Brief') IBC - Waiver of rights under contract such as debenture trust deed cannot be implied if agreement explicitly requires such waiver to be in writing: SC (See 'Legal Desk') IBC - Manner in which bank classifies loan as non-performing asset for accounting or provisioning purposes does not determine IBC, if debt was restructured and acknowledged in fresh agreements: SC (See 'Legal Desk') IBC - corporate restructuring under IBC must be prioritized over stalled and ineffective proceedings under Companies Act to protect public funds and larger economic interest: SC (See 'Legal Desk') IBC - NCLT can't Reject Sec 7 application citing corporate debtor's financial health, once twin requirements of debt & default are established: SC LB (See 'Legal Desk') IBC - Moratorium u/s 14 of IBC is intended to preserve debtor's estate from creditor actions aimed at debt recovery, but does not interdict sovereign proceedings in rem for attachment or confiscation under Benami Act: SC (See 'Legal Desk') Supreme Court Clears Path For Single Insolvency Proceedings Against Linked Group Companies (See CORP EINSICHT)

Print

MoS reaffirms India's commitment to global pharmaceutical standardization

Published: Feb 06, 2025

By TIOLCorplaws News Service

NEW DELHI, FEB 06, 2025: UNION Minister of State for Health and Family Welfare, Anupriya Patel delivered the keynote address at the 15th International Meeting of World Pharmacopoeias (IMWP), hosted by the Indian Pharmacopoeia Commission (IPC) under the aegis of the Ministry of Health and Family Welfare, Government of India, in collaboration with the World Health Organization (WHO), here today. The meeting brought together global pharmacopoeial leaders, regulatory authorities, and industry stakeholders to deliberate on key issues related to pharmaceutical standards and harmonization.

Addressing the gathering, Patel reaffirmed India's commitment to global pharmaceutical standardization and regulatory convergence. She highlighted India's role as the "Pharmacy of the World" and emphasized the importance of ensuring access to high-quality medicines globally. She stated that the IMWP serves as a vital platform to foster international collaboration in pharmacopoeial science and regulatory harmonization.

On this occasion, the Union Minister also released the IPC Newsletter 2024 and a special IPC video film, which showcase India's advancements in pharmacopoeial science and the Commission's efforts in ensuring high-quality pharmaceutical standards. The video film can be accessed at the following link: https://www.youtube.com/watch?v=MCdAZodvOSM .

Punya Salila Srivastava, Secretary, Ministry of Health and Family Welfare, underscored the significance of global partnerships in strengthening pharmaceutical quality standards. She reiterated India's efforts in aligning regulatory frameworks with international best practices and ensuring the availability of safe and effective medicines worldwide.

Dr. Rajeev Singh Raghuvanshi, Secretary-cum-Scientific Director, IPC, and Drugs Controller General (India), highlighted IPC's contributions in setting global benchmarks in pharmacopoeial science. He elaborated on IPC's initiatives, including the IP Online platform, which enhances accessibility and usability of Indian Pharmacopoeia standards. He emphasized the role of scientific advancements and regulatory cooperation in shaping global pharmaceutical standards.

Dr. Roderico H. Ofrin, WHO Representative to India, commended India's leadership in pharmacopoeial standard-setting and emphasized the importance of regulatory harmonization in ensuring patient safety and public health.

The 15th IMWP is set to facilitate discussions on key focus areas, including:

- Updates on recommendations from the 14th IMWP and review of progress on harmonization initiatives.

- Emerging issues in impurity assessment (Q3) and the implications of ICH Q6 guidelines on pharmacopoeial monograph specifications.

- Defining the IMWP Charter to establish a long-term governance structure for the forum.

- Enhancing collaboration among global pharmacopoeias and regulatory bodies, with updates from the Pharmacopoeial Discussion Group (PDG).

- Promotion of environmental sustainability in pharmacopoeial practices and pharmaceutical manufacturing standards.

- Finalization of reports for the 15th IMWP and preparatory discussions for the 16th IMWP.

The deliberations during the IMWP will reinforce the role of pharmacopoeias in ensuring the quality, safety, and efficacy of medicines. The outcomes of the meeting will guide future collaborations in standard-setting and regulatory harmonization.

The 15th IMWP, which commenced today, will conclude on 7th February 2025. The discussions held over these three days will set the stage for further strengthening global pharmacopoeial cooperation and enhancing pharmaceutical quality assurance.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.